Table 1. TNM classification of lung cancer in the 6th edition (5, 6) and proposal for the 7th edition (25).
6th edition | Proposal for the 7th edition | |||
T | TX | Primary tumor cannot be assessed, or evidence of malignant cells in sputum or bronchial lavage fluid but no visualization of tumor on imaging or bronchoscopy | TX | Primary tumor cannot be assessed, or evidence of malignant cells in sputum or bronchial lavage fluid but no visualization of tumor on imaging or bronchoscopy |
T0 | No evidence of primary tumor | T0 | No evidence of primary tumor | |
Tis | Carcinoma in situ | Tis | Carcinoma in situ | |
T1 | Tumor ≤ 3 cm greatest diameter, surrounded by lung tissue or visceral pleura, no bronchoscopic evidence of invasion proximal to the lobar bronchus (i.e., main bronchi are free)*1 | T1 | Tumor ≤ 3 cm greatest diameter, surrounded by lung tissue or visceral pleura, no bronchoscopic evidence of infiltration proximal to the lobar bronchus (i.e., main bronchi are free)*1 | |
T1a | Tumor ≤ 2 cm greatest diameter | |||
T1b | Tumor > 2 but ≤ 3 cm greatest diameter | |||
T2 | Tumor > 3 cm or tumor with one of the following features: | T2 | Tumor > 3 but ≤ 7 cm with one of the following features: | |
|
|
|||
Associated atelectasis or obstructive pneumonia extending as far as the hilus but not involving the whole lung | ||||
T2a | Tumor > 3 but ≤ 5 cm greatest diameter | |||
T2b | Tumor > 5 but ≤ 7 cm greatest diameter | |||
T3 | Tumor of any size with direct invasion of one of the following structures: | T3 | Tumor > 7 cm or any tumor with direct invasion of one of the following structures: | |
|
|
|||
or tumor in the main bronchus < 2 cm distal to the carina, without involvement of the carina and without associated atelectasis or obstructive pneumonia of the whole lung | or tumor in the main bronchus < 2 cm distal to the carina, without involvement of the carina and without associated atelectasis or obstructive pneumonia of the whole lung or satellite tumor nodule(s) in the same lobe | |||
T4 | Tumor of any size invading one of the following structures: | T4 | Tumor of any size invading one of the following structures: | |
|
|
|||
or separate tumor nodule(s) in the same lobe or tumor with malignant pleural* 2 or pericardial effusion | ||||
N | NX | Regional lymph nodes could not be evaluated | NX | Regional lymph nodes could not be evaluated |
N0 | No regional lymph node metastases | N0 | No regional lymph node metastases | |
N1 | Metastasis/metastases in the ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension of the primary tumor | N1 | Metastasis/metastases in the ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary lymph nodes, including involvement by direct extension of the primary tumor | |
N2 | Metastasis/metastases in the ipsilateral mediastinal and/or subcarinal lymph nodes | N2 | Metastasis/metastases in the ipsilateral mediastinal and/or subcarinal lymph nodes | |
N3 | Metastasis/metastases in the contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene or supraclavicular lymph nodes | N3 | Metastasis/metastases in the contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene or supraclavicular lymph nodes | |
M | MX | Distant metastases could not be evaluated | MX | Distant metastases could not be evaluated |
M0 | No distant metastases | M0 | No distant metastases | |
M1 | Distant metastases, including separate tumor nodules in another pulmonary lobe | M1 | Distant metastases | |
M1a | Separate tumor nodule(s) in a contralateral lobe; tumor with pleural*2 nodes or malignant pleural (or pericardial) effusion | |||
M1b | Distant metastases |
*1 A superficially extending tumor with invasion limited to the bronchial wall is always classified as T1.
*2 In patients with lung cancer, pleural and pericardial effusions are usually due to the tumor. In a few patients, however, if multiple cytological examinations are negative for the presence of tumor cells, the effusion is not hemorrhagic and is not an exudate. If these factors are present, and if the clinical evaluation also indicates that the effusion is not caused by the lung cancer, the effusion should not be taken into account as a staging criterion.